daunomycinone has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, HS; Jang, S; Lee, JH; Park, BG; Park, CJ; Seo, EJ | 1 |
| Azarnia, N; Bolanowska, W; Gessner, T; Goldberg, J; Grunwald, H; Joyce, R; Preisler, HD; Vogler, WR | 1 |
2 other study(ies) available for daunomycinone and Acute Disease
| Article | Year |
|---|---|
Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Bone Marrow Cells; Cell Lineage; Cell Transformation, Neoplastic; Chromosome Deletion; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 7; Cytarabine; Drug Therapy, Combination; Humans; Immunophenotyping; Karyotyping; Leukemia, Erythroblastic, Acute; Male; Middle Aged; Monosomy; Naphthacenes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence | 2011 |
Plasma levels of daunorubicin metabolites and the outcome of ANLL therapy.
Topics: Acute Disease; Biotransformation; Daunorubicin; Humans; Injections, Intravenous; Kinetics; Leukemia; Naphthacenes | 1987 |